Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform

Cancer Genetics - Tập 258 - Trang 57-60 - 2021
Darren King1, Charles E. Foucar1, Vincent Ma1, Lydia Benitez2, Anthony J. Perissinotti2, Bernard L. Marini2, Dan Robinson3, Rupali Roy Bhave4, Dale Bixby1
1Division of Hematology and Medical Oncology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan, USA
2Department of Pharmacy, Michigan Medicine, Ann Arbor, Michigan, USA
3Michigan Center for Translational Pathology, Michigan Medicine, Ann Arbor, Michigan, USA
4Division of Hematology and Medical Oncology, Wake Forrest University, Winston-Salem, North Carolina, USA

Tài liệu tham khảo

Rowley, 1977, 15/17 translocation, a consistent chromosome change in acute promyelocytic leukemia, The Lancet, 309, 549, 10.1016/S0140-6736(77)91415-5

Sanz, 2000, Blood, 96, 1247

Abedin, 2016, Acute promyelocytic leukemia: preventing early complications and late toxicities, Hematology Am Soc Hematol Educ Program, 2016, 10, 10.1182/asheducation-2016.1.10

Grimwade, 2000, Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party, Blood, 96, 1297

Adams, 2015, Acute promyelocytic leukemia: a review and discussion of variant translocations, Arch Pathol Lab Med, 139, 1308, 10.5858/arpa.2013-0345-RS

Won, 2013, OBFC2A/RARA: a novel fusion gene in variant acute promyelocytic leukemia, Blood, 121, 1432, 10.1182/blood-2012-04-423129

Yin, 2015, Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia, J Natl Compr Canc Netw, 13, 19, 10.6004/jnccn.2015.0005

Shimomura, 2016, New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion, Cancer Sci, 107, 1165, 10.1111/cas.12970

Catalano, 2007, The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia, Blood, 110, 4073, 10.1182/blood-2007-06-095554

Mannan, 2020, Genotypic and phenotypic characteristics of acute promyelocytic leukemia translocation variants, Hematol Oncol Stem Cell Ther, 13, 189, 10.1016/j.hemonc.2020.05.007

Langabeer, 2017, Molecular profiling: a case of ZBTB16-RARA acute promyelocytic leukemia, Case Rep Hematol, 2017

Powell, 2010, Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American leukemia intergroup study C9710, Blood, 116, 3751, 10.1182/blood-2010-02-269621

Sanz, 2015, All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies, Ann Hematol, 94, 1347, 10.1007/s00277-015-2393-0

Roychowdhury, 2011, Personalized oncology through integrative high-throughput sequencing: a pilot study, Sci Transl Med, 3, 10.1126/scitranslmed.3003161

Cobain, 2021, Assessment of clinical benefit of integrative genomic profiling in advanced solid tumors, JAMA Oncol, 10.1001/jamaoncol.2020.7987

Robinson, 2017, Integrative clinical genomics of metastatic cancer, Nature, 548, 297, 10.1038/nature23306

Wu, 2018, Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer, Cell, 173, 1770, 10.1016/j.cell.2018.04.034

Pollyea, 2021, NCCN guidelines insights: acute myeloid leukemia, version 2.2021, J Natl Compr Canc Netw, 19, 16, 10.6004/jnccn.2021.0002

Sobas, 2020, PLZF-RARα, NPM1-RARα, and other acute promyelocytic leukemia variants: the PETHEMA registry experience and systematic literature review, Cancers (Basel), 12, 1313, 10.3390/cancers12051313

Poiré, 2014, Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype, Leuk Lymphoma, 55, 1523, 10.3109/10428194.2013.842985

Lucena-Araujo, 2019, Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia, Blood, 134, 951, 10.1182/blood.2019000239

Shen, 2015, Mutations of epigenetic modifier genes as a poor prognostic factor in acute promyelocytic leukemia under treatment with all-trans retinoic acid and arsenic trioxide, EBioMedicine, 2, 563, 10.1016/j.ebiom.2015.04.006

De Botton, 2000, Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial, Br J Haematol, 111, 801, 10.1111/j.1365-2141.2000.02442.x

Cervera, 2010, Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy, Haematologica, 95, 424, 10.3324/haematol.2009.013243

Thông tin
Thông tin xuất bản

Cancer Genetics

Tập 258

57-60

Thông tin tác giả